60482-95-3
60482-95-3 structure
- Name: Neurotensin (8-13) acetate salt
- Chemical Name: 2-[[2-[[2-[[1-[2-[[2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoic acid
- CAS Number: 60482-95-3
- Molecular Formula: C38H64N12O8
- Molecular Weight: 816.99000
- Catalog: Peptides
- Create Date: 2018-12-28 17:20:07
- Modify Date: 2026-07-03 12:59:06
-
Neurotensin (8-13) is an active fragment of Neurotensin,. Neurotensin(8-13) results in a decrease in cell-surface NT1 receptors (NTR1) density.
| Name | 2-[[2-[[2-[[1-[2-[[2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoic acid |
|---|---|
| Synonyms |
L-g-L-g-L-Pro-L-Tyr-L-Ile-L-Leu-OH
neurotensin fragment acetate AC-G-G-PRO-TYR-ILE-LEU: AC-RRPYIL Neurotensin(8-13) Neurotensin Fragment acetate salt >= (HPLC) Neurotensin H-g-g-Pro-Tyr-Ile-Leu-OH Neurotensin H-G-G-PRO-TYR-ILE-LEU-OH NEUROTENSIN FRAGMENT ACETATE SALT L-ginyl-L-ginyl-L-prolyl-L-tyrosyl-L-isoleucyl-L-leucine G-G-PRO-TYR-ILE-LEU ACETATE SALT G-G-PRO-TYR-ILE-LEU Neurotensin(3TFA) NEUROTENSIN, FRAGMENT L-Leucine, L-ginyl-L-ginyl-L-prolyl-L-tyrosyl-L-isoleucyl RRPYIL |
| Description | Neurotensin (8-13) is an active fragment of Neurotensin,. Neurotensin(8-13) results in a decrease in cell-surface NT1 receptors (NTR1) density. |
|---|---|
| Related Catalog | |
| Target |
NTR1[1] |
| In Vitro | Receptor internalization induced by Neurotensin(8-13) results in a decrease in cell-surface NT1 receptors (NTR1) density. The receptor downregulation in response to high extracellular concentrations of the peptide has been described for Neurotensin (NT) in HT-29 cells and in rat primary cultured neurons. Reappearance of the receptors on the cell surface is also different[1]. |
| Kinase Assay | Binding assays are performed on whole HT-29 cells at confluence. A day before the assay, cells (106 cells/0.4 mL, equivalent to 0.3 mg protein) are placed in 48-well plates. A special binding buffer that includes protease inhibitors (50 mM HEPES, 125 mM NaCl, 7.5 mM KCl, 5.5 mM MgCl2, 1 mM EGTA, 5 g/L bovine serum albumin, 2 mg/L chymostatin, 100 mg/L soybean trypsin inhibitor, 50 mg/L bacitracin, pH 7.4) is used for the experiments. In inhibition studies, cells are incubated for 1 h at 37°C in triplicate with 25,000 cpm of 125I-NT and variable concentrations (0.001-3,000 nM) of unlabeled NT(8-13), unlabeled NT-VIII, or NT-VIII labeled with natRe (final volume of 0.2 mL per well). The cells are then washed twice with cold binding buffer and afterward are solubilized with 1N NaOH at 37°C (0.4 mL per well). The activity is determined in a γ-counter. In saturation studies, cells are incubated in triplicate with increasing concentrations (0.1-10 nM) of 99mTc(CO)3NT-VIII for 1 h at 37°C (final volume, 0.2 mL per well). The concentrations of total technetium (99+99mTc) are equivalent to 0.2-20 MBq 99mTc activity per well. After 2 washings with the same binding buffer as before, the cells are then solubilized with 1N NaOH at 37°C (0.4 mL per well). The bound radioactivity is measured in the γ-counter. Nonspecific binding is determined with 1 μM unlabeled NT(8-13)[1]. |
| References |
| Density | 1.4 g/cm3 |
|---|---|
| Molecular Formula | C38H64N12O8 |
| Molecular Weight | 816.99000 |
| Exact Mass | 816.49700 |
| PSA | 344.06000 |
| LogP | 3.47920 |
| Index of Refraction | 1.642 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |